James Hardie Industries Plc - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by James Hardie Industries Plc on January 23, 2018, for the month of January 2018. The filing serves as a notification of the Company's Q3FY18 Results, which are included as Exhibit 99.1. The registrant is a foreign private issuer headquartered in Dublin, Ireland, and files annual reports on Form 20-F.
Key Financial Metrics
The provided filing text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a cover sheet referencing the Q3FY18 Results Notification (Exhibit 99.1) where such financial details are located, but the text of the results is not included in the source content.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It references the Q3FY18 results but does not summarize the comparative performance data within this document.
Guidance, Outlook, and Risks
The document contains an extensive "Forward-Looking Statements" section cautioning investors against undue reliance on future projections. Key risks and uncertainties identified include:
- Asbestos Liabilities: Risks related to prior asbestos product manufacture, contributions to the Asbestos Injuries Compensation Fund (AICF), potential shortfalls in the AICF, and currency exchange impacts on asbestos liabilities.
- Legal and Regulatory: Exposure to product liability, environmental, consumer class action, and other legal proceedings, including tax audits and proceedings.
- Market Conditions: Dependence on US and Asia Pacific housing markets, new home construction levels, consumer confidence, and economic conditions.
- Operational Risks: Costs associated with plant closures or capital expenditure projects, raw material supply and costs, and competition.
- Financial Risks: Currency exchange risks, ability to renew credit facilities, and potential tax charges.
- Acquisitions: Risks related to the consummation and integration of the Fermacell acquisition.
The Company explicitly states it assumes no obligation to update forward-looking statements except as required by law.
Investor Verification Checklist
- Review Exhibit 99.1 (Q3FY18 Results Notification) for actual financial figures, as they are not present in this cover filing.
- Verify the status and funding adequacy of the Asbestos Injuries Compensation Fund (AICF).
- Monitor the integration progress and financial impact of the Fermacell acquisition.
- Assess current housing market conditions in the US and Asia Pacific regions as primary drivers of demand.
- Check for updates on pending legal proceedings and tax audits mentioned in the risk factors.